Polymorphism of the ERα and CYP1B1 genes in endometrial cancer in a Polish subpopulation

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 2, 2010, Pages 311-317

  Sliwinski, Tomasz ^a   Sitarek, Przemyslaw ^a   Stetkiewicz, Tomasz ^b   Sobczuk, Anna ^b   Blasiak, Janusz ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

CYP1B1; Endometrial cancer; ER ; Gene polymorphism

Indexed keywords

CYTOCHROME P450 1B1; ESTROGEN RECEPTOR ALPHA; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOMETRIUM CANCER; FEMALE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLAND; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CARCINOMA; CAUCASIAN; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; REGRESSION ANALYSIS; RISK; RISK FACTOR;

AGED; ARYL HYDROCARBON HYDROXYLASES; CARCINOMA; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS;

EID: 77950271312     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2009.01143.x     Document Type: Article

References (42)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999 49 : 33 64.
2. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ II., Chen VW. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 1996 88 : 919 926.
3. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 2004 94 : 2104 2111.
4. Li JJ, Li SA, Klicka JK, Parsons JA, Lam LK. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 1983 43 : 5200 5204.
5. Li JJ, Li SA, Oberley TD, Parsons JA. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res 1995 55 : 4347 4351.
6. Li JJ, Hou X, Bentel J, Yazlovitskaya EM, Li SA. Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: some unique properties of a synthetic estrogen. Carcinogenesis 1998 19 : 471 477.
7. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17b-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996 93 : 9776 9781.
8. Han X, Liehr JG. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 1994 15 : 997 1000.
9. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000 60 : 235 237.
10. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem 1991 110 : 407 411.
11. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T. The molecular mechanisms of two common polymorphisms of drug oxidation: evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica 1986 16 : 449 464.
12. Weiderpass E, Persson I, Melhus H, Wedrén S, Kindmark A, Baron JA. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000 21 : 623 627.
13. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001 276 : 36869 36872.
14. Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005 23 : 1616 1622.
15. Jordan VC. Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 2004 5 : 207 213.
16. McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science 2002 296 : 1642 1644.
17. Rayter Z. Steroid receptors in breast cancer. Br J Surg 1991 78 : 528 535.
18. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998 58 : 5038 5041.
19. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res 2003 63 : 3913 3918.
20. Lippke JA, Strzempko MN, Raia FF, Simon SL, French CK. Isolation of intact high-molecular-weight DNA by using guanidine isothiocyanate. Appl Environ Microbiol 1987 53 : 2588 2589.
21. Bejjani BA, Lewis RA, Tomey KF et al. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998 62 : 325 333.
22. Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res 2001 61 : 97 102.
23. Sutter TR, Tang YM, Hayes CL et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994 269 : 13092 13099.
24. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000 60 : 3440 3444.
25. Stoilov I, Akarsu AN, Alozie I. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 1998 62 : 573 584.
26. Aklillu E, Oscarson M, Hidestrand M, Leidvik B, Otter C, Ingelman-Sundberg M. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Mol Pharmacol 2002 61 : 586 594.
27. Coughlin SS, Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999 8 : 1023 1032.
28. De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002 11 : 489 492.
29. Tang YM, Green BL, Chen GF et al. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 2000 10 : 761 766.
30. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochem Biophys Res Commun 2002 296 : 820 826.
31. Chang BL, Zheng SL, Isaacs SD et al. Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer. Br J Cancer 2003 89 : 1524 1529.
32. Ambrosone CB, Freudenheim JL, Graham S et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995 55 : 3483 3485.
33. Kumar A, Manjunath G, Basavaraj MG et al. Role of CYP1B1, MYOC, OPTN and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients. Mol Vision 2007 13 : 667 676.
34. Bethke L, Webb E, Sellick G et al. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer 2007 7 : 123.
35. Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutation Res 2003 98 : 356 368.
36. Roodi N, Bailey LR, Kao WY et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995 87 : 446 451.
37. Hsiao WC, Young KC, Lin SL, Lin PW. Estrogen receptor-α polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Cancer Lett 2002 178 : 175 180.
38. Shin A, Kang D, Nishio H et al. Estrogen receptor alpha gene polymorphisms and breast cancer risk. Breast Cancer Res Treatment 2003 80 : 127 131.
39. Miyoshi Y, Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Biomed Pharmacother 2003 57 : 471 481.
40. Cicek MS, Liu X, Casey G, Witte JS. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11a in prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 2002 11 : 505 512.
41. Thyagarajan B, Brott M, Mink P et al. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett 2004 207 : 183 189.
42. Rylander-Rudqvist T, Wedren S, Jonasdottir G et al. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004 13 : 1515 1520.